Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

Managing patients with KRAS G12C-mutant NSCLC: Real-world perspectives (ID 330)

Lecture Time
12:20 - 12:35
Speakers
  • Keith M. Kerr, Aberdeen, GB
  • Solange Peters, Lausanne, CH
  • Joop De Langen, Amsterdam, NL
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00